Source:

John A. Hovanesian, MD, FACS, and Jim Mazzo



Disclosures: Hovanesian reports a financial interest in 1-800-DOCTORS, Acufocus, Aerie, Alcon, Allegro, Allergan, BlephEx, Cord, Eyedetec, Glaukos, Guardion, Johnson & Johnson Vision, Katena, Ivantis, Kala, MDbackline, Novartis, Ocular Therapeutix, Omeros, Sarentis Ophthalmics, Sensimed, Tear Film Innovations and Valeant. Mazzo reports a financial interest in Avellino Labs, Carl Zeiss Meditec, Centricity, IanTech, LensGen, Neurotech, ReFocus and Visus.

September 06, 2020
1 min watch
Save

VIDEO: Hovanesian interviews Mazzo on ophthalmology's future in coronavirus era, part 6

Source:

John A. Hovanesian, MD, FACS, and Jim Mazzo



Disclosures: Hovanesian reports a financial interest in 1-800-DOCTORS, Acufocus, Aerie, Alcon, Allegro, Allergan, BlephEx, Cord, Eyedetec, Glaukos, Guardion, Johnson & Johnson Vision, Katena, Ivantis, Kala, MDbackline, Novartis, Ocular Therapeutix, Omeros, Sarentis Ophthalmics, Sensimed, Tear Film Innovations and Valeant. Mazzo reports a financial interest in Avellino Labs, Carl Zeiss Meditec, Centricity, IanTech, LensGen, Neurotech, ReFocus and Visus.

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

In this final video installment from their conversation, OSN Cataract Surgery Section Editor John A. Hovanesian, MD, FACS, and ophthalmic industry veteran Jim Mazzo tackle reimbursement and the future of ophthalmology meetings and other topics.